Limitations of the European barrier crash testing regulation relating to occupant safety.


Journal

Accident; analysis and prevention
ISSN: 1879-2057
Titre abrégé: Accid Anal Prev
Pays: England
ID NLM: 1254476

Informations de publication

Date de publication:
Dec 2019
Historique:
received: 10 12 2018
revised: 11 06 2019
accepted: 17 07 2019
pubmed: 29 9 2019
medline: 25 12 2019
entrez: 29 9 2019
Statut: ppublish

Résumé

The safety of roadside restraint systems in Europe is ensured by the EN 1317 regulation. The ability of the barrier to mitigate injury to the occupants of vehicles is tested according to two occupant injury metrics: Acceleration Severity Index (ASI) and Theoretical Head Impact Velocity (THIV). Both metrics aim to predict occupant head injury from vehicle kinematics, despite the potential to easily measure actual head kinematics from instrumented Anthropomorphic Test Dummies, a non-instrumented version of which is already required according to the regulation. Retrospective data provided by AISICO S.r.l. for 33 certificated barrier tests, where acceleration of the dummy's head had also been recorded, were re-analysed. ASI and THIV were compared with Head Injury Criterion (HIC

Identifiants

pubmed: 31563016
pii: S0001-4575(18)30401-9
doi: 10.1016/j.aap.2019.07.015
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

105239

Informations de copyright

Copyright © 2019. Published by Elsevier Ltd.

Auteurs

Jasper Chell (J)

Department for Health, University of Bath, Bath, UK; Interuniversity Centre of Bioengineering of the Human Neuromusculoskeletal System, University of Rome "Foro Italico", Roma, Italy; Department of Movement, Human and Health Sciences, University of Rome "Foro Italico", Roma, Italy.

Carola Elea Brandani (CE)

Interuniversity Centre of Bioengineering of the Human Neuromusculoskeletal System, University of Rome "Foro Italico", Roma, Italy; Research and Development division, AISICO s.r.l., Rome, Italy.

Stefano Fraschetti (S)

Interuniversity Centre of Bioengineering of the Human Neuromusculoskeletal System, University of Rome "Foro Italico", Roma, Italy; Research and Development division, AISICO s.r.l., Rome, Italy.

Joe Chakraverty (J)

Department for Health, University of Bath, Bath, UK; Interuniversity Centre of Bioengineering of the Human Neuromusculoskeletal System, University of Rome "Foro Italico", Roma, Italy; Department of Movement, Human and Health Sciences, University of Rome "Foro Italico", Roma, Italy.

Valentina Camomilla (V)

Interuniversity Centre of Bioengineering of the Human Neuromusculoskeletal System, University of Rome "Foro Italico", Roma, Italy; Department of Movement, Human and Health Sciences, University of Rome "Foro Italico", Roma, Italy. Electronic address: valentina.camomilla@uniroma4.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH